Cargando…

675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program

Detalles Bibliográficos
Autores principales: Puttagunta, Sailaja, Wilcox, Mark, Boucher, Helen, Talbot, George, Dunne, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781904/
http://dx.doi.org/10.1093/ofid/ofu052.383
_version_ 1783295067490877440
author Puttagunta, Sailaja
Wilcox, Mark
Boucher, Helen
Talbot, George
Dunne, Michael
author_facet Puttagunta, Sailaja
Wilcox, Mark
Boucher, Helen
Talbot, George
Dunne, Michael
author_sort Puttagunta, Sailaja
collection PubMed
description
format Online
Article
Text
id pubmed-5781904
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57819042018-03-01 675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program Puttagunta, Sailaja Wilcox, Mark Boucher, Helen Talbot, George Dunne, Michael Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781904/ http://dx.doi.org/10.1093/ofid/ofu052.383 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Puttagunta, Sailaja
Wilcox, Mark
Boucher, Helen
Talbot, George
Dunne, Michael
675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
title 675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
title_full 675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
title_fullStr 675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
title_full_unstemmed 675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
title_short 675 Outcomes of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) by vancomycin dosing regimen and vancomycin trough serum concentrations in the DISCOVER Program
title_sort 675 outcomes of acute bacterial skin and skin structure infections (absssi) by vancomycin dosing regimen and vancomycin trough serum concentrations in the discover program
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781904/
http://dx.doi.org/10.1093/ofid/ofu052.383
work_keys_str_mv AT puttaguntasailaja 675outcomesofacutebacterialskinandskinstructureinfectionsabsssibyvancomycindosingregimenandvancomycintroughserumconcentrationsinthediscoverprogram
AT wilcoxmark 675outcomesofacutebacterialskinandskinstructureinfectionsabsssibyvancomycindosingregimenandvancomycintroughserumconcentrationsinthediscoverprogram
AT boucherhelen 675outcomesofacutebacterialskinandskinstructureinfectionsabsssibyvancomycindosingregimenandvancomycintroughserumconcentrationsinthediscoverprogram
AT talbotgeorge 675outcomesofacutebacterialskinandskinstructureinfectionsabsssibyvancomycindosingregimenandvancomycintroughserumconcentrationsinthediscoverprogram
AT dunnemichael 675outcomesofacutebacterialskinandskinstructureinfectionsabsssibyvancomycindosingregimenandvancomycintroughserumconcentrationsinthediscoverprogram